Montserrat Bosch Ferrer (Montserrat Bosch)

Years Active: 2022-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Arantxa Sancho-López, Belén Ruiz-Antorán, Teresa Iglesias Hernangómez, Almudena Ramírez-García, Irene Gómez-Estévez, Judith Sanabria-Cabrera, Roser Llop Rius, Consuelo Pedrós, Diana Campodonico, Silvia Jiménez-Jorge, Amelia García Luque, Lucienne Costa Frossad França, Eva Montané, Ana Aldea-Perona, Nieves Téllez Lara, Montserrat Bosch Ferrer, Consuelo Rodriguez Jiménez, Elvira Bonilla-Toyos, Julia Sabín Muñoz, Cristina Avendaño-Solá, Maria Rosario Blasco Quilez, null On Behalf Of The Realhes-Study Group
The Need for the Closer Monitoring of Novel Drugs in MS: A Siponimod Retrospective Cohort Study (Realhes Study). Journal of clinical medicine 12 (20) (2023)
Cristina Aguilera, Immaculada Danés, Elena Guillén, Alba Vimes, Montserrat Bosch Ferrer, Gloria Cereza, Adrián Sánchez-Montalvá, Isabel Campos-Varela, Marta Miarons, Jaume Mestre-Torres, Antònia Agustí
Safety of Drugs Used during the First Wave of COVID-19: A Hospital-Registry-Based Study. Diagnostics (Basel, Switzerland) 12 (7) (2022)

Montserrat Bosch Ferrer.css-eqlu8i{font-size:small;padding-left:4px;} (Montserrat Bosch)